Department of Medicine

December 12, 2025

Lucy Spalluto and Jennifer Lewis awarded $1 million lung screening grant

Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.

By Derek Scancarelli
December 10, 2025

Sedative choice could improve outcomes for breathing tube patients

It’s the first study to demonstrate cardiovascular risks of high doses of ketamine (low blood pressure, arrhythmia), side effects that have not been well studied in the past.

By Craig Boerner
(iStock image)
December 8, 2025

Interim data reported for multiple myeloma off-the-shelf CAR-T therapy  

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

By Tom Wilemon
(photo by Erin O. Smith)
December 4, 2025

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

By Tom Wilemon
December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

By Leigh MacMillan
An initiative at VUMC is helping patients recover more quickly from major surgery, leave the hospital earlier and have fewer side effects from their pain management. (photo by Joe Howell)
December 2, 2025

Ketamine fails surgical recovery trial

In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery.

By Paul Govern
December 1, 2025

Timothy Sterling receives $5.7 million to study tuberculosis transmission

Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.
By Paul Govern
November 26, 2025

Protein plays dual roles in repairing damaged kidney

These findings were unexpected and demonstrate that the actin cytoskeleton repairs cell organelles like mitochondria in a regulated way.
By Bill Snyder
November 14, 2025

Andrew DeFilippis named director of VUMC’s Division of Cardiovascular Medicine

He serves as associate chief of staff at Vanderbilt University Hospital and served as the medical director of the Cardiovascular Intensive Care Unit from 2020 to 2025.
By Matt Batcheldor
November 13, 2025

Vanderbilt Institute for Global Health marks 20 years 

Since its founding in 2005, VIGH has grown from a small team focused on HIV/AIDS research to an institute with projects in more than 20 countries and more than 150 faculty members and staff.
By Kristin Centers
November 13, 2025

VUMC’s Wesley Ely inducted into the American Academy of Sciences and Letters

Established in 2023, the academy honors outstanding scholarly achievements reflecting “independence of mind and intellectual courage” in the arts, sciences and learned professions.
By Bill Snyder
November 12, 2025

New study reveals long-term impacts on Stevens-Johnson syndrome survivors 

SJS and TEN occur when a medication triggers the immune system to attack the body’s own skin and mucous membranes.
By Kylie Avery
November 11, 2025

Drug resistant infections are on the rise: Experts emphasize education, awareness

Teams at VUMC and Monroe Carell are focused on reaching more clinicians, patients and families through the Vanderbilt Antimicrobial Stewardship Program.
By Jessica Pasley
1 2 3 … 124